• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Optimize EP Launches CaRM Cardiac Device Data Management Platform

    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR

    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation

    Moon Surgical Expands Leadership Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    FUTEK Advanced Sensor Technology Inc.

    Medicoil

    MW Life Sciences

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    Unicep

    Element

    MW Life Sciences

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    COVID-19’s Impact on the Medical Device Supply Chain

    ...

    Tony Freeman, President, A.S. Freeman Advisors LLC04.01.20
    On March 11, the World Health Organization declared COVID-19 a global pandemic, prompting the shutdown of much of civilized life. Conventional wisdom holds that medtech companies are largely insulated from economic disruption due to the steady demand for medical products and procedures. This notion, however, could be turned on its head as hospitals delay elective procedures in order to free up space for critically ill virus patients. A careful review of all the issues associated with the pandemic shows that COVID-19 will have numerous short-, mid-, and long-term impacts on the medical device industry. Companies that operate regularly in the supply chain should expect to see the emergence of stronger, more conservatively financed, multi-site suppliers as a long-term outcome of the pandemic.

    Where to Find Guidance
    The fast-moving, evolving coronavirus pandemic guarantees challenges for businesses worldwide. As managers plan to ride out the disruption, many are finding they have no point of reference around which to organize their efforts. While supply chain executives have lived through banking crises, slowdowns, staff shortages, and even weather emergencies, few alive today have lived through a rapidly spreading health disaster. Where should a manager look to understand how the disruption is unfolding and how it will hit their company’s segment of the medical device industry? Traditionally, the supply chain has looked to OEM sales as the best indicator of industry outlook. In this situation, it is more useful to look beyond the OEMs to their customers—the hospitals, clinics, and physicians that comprise the provider segment—as the first movers that will set in motion the chain of events to which suppliers must react.

    As the coronavirus crisis expands, providers are rapidly shifting their practice and purchasing priorities to meet the demands of a pandemic. Two changes in the coming months seem certain: The first is that medical staff and equipment will be shifted to fight the virus and its complications. Doctors, nurses, hospital rooms, diagnostic labs, and capital equipment will be shifted from traditional uses to screening and treating coronavirus patients. The second is that critical procedures will still take place, though with some minor delays for the less time-sensitive treatments. Non-critical procedures will be delayed or cancelled for the foreseeable future. These are only two of the changes likely to occur in the coming weeks. Still, we can project their short-term, mid-term, and long-term impact on the supply chain.

    Short-Term Impacts: Commercial
    Over the next six months, there will be a series of demand shocks, both positive and negative, as medical device OEMs and their suppliers respond to providers’ changing needs. Beneficiaries of the epidemic will be vendors of basic hospital supplies, as healthcare facilities fill to capacity with coronavirus victims. Many of these products will be low-margin disposables including masks, wipes, disposable hospital room products, and standard examination supplies. Demand for these products should increase markedly for a few weeks but a robust supplier base will be able to rapidly ramp to meet demand. Also benefiting from demand but more constrained in capacity will be manufacturers of diagnostic consumables and imaging suppliers as more patients are tested for coronavirus and those diagnosed are tracked for respiratory issues.

    Beyond these “front and center” products, an area likely to be tested by the pandemic will be telehealth devices and services. For the next few months, this product class—largely considered a novelty or luxury up until now—has the opportunity to demonstrate real value as traditional healthcare services become overwhelmed by patient load demands.

    Will the financial impact of these increases in demand be significant? With the exception of the diagnostics companies selling coronavirus tests, the uptick in device demand will be modest when compared against the broadly diversified product portfolios of the OEM suppliers. A few companies will garner higher sales in a few product lines, many of which are low-margin commodity products. The overall impact will not be exceptional, however.

    In the short-term, demand will decline across the rest of the device industry. Manufacturers of critical devices and components will experience a modest slowdown in orders for two reasons. Device management executives at OEMs responsible for established products will be uncertain as to demand, given the rapidly evolving news about the numbers of infected and disruptions affecting medicines and devices. Thus, they will tightly manage inventories. Reorders will take place, though at a slower pace as OEMs strive to understand the full impact of the virus on their businesses. Managers overseeing new product launches will also act more slowly, hesitant to make bold moves in uncertain times. The impact of both these trends will prove operationally disruptive to suppliers but should have only a modest revenue impact in 2020 for OEMs.

    OEMs of non-critical devices and their suppliers will face greater challenges in the coming months. No area of medicine will be impacted by demand shock as much as orthopedics. Orthopedic procedures are rarely considered critical and often have long recovery periods, requiring several trips to healthcare facilities. The possibility of multiple interactions with providers at institutions handling coronavirus cases will cause potential patients to choose ibuprofen over surgery. The orthopedic problem is compounded by the economic disruption certain to be caused by the virus. As stated, orthopedic procedures often have long recovery times; with the possibility of a recession looming, workers fearful of possible layoffs will be hesitant to take extended time off for joint replacement procedures or spinal fusions. Amplifying these delays in surgeries is the fact that orthopedic OEMs, by the very nature of their product lines, have significantly more inventory than a comparably sized non-orthopedic OEM. As was the case in the 2008 recession, orthopedic companies are quick to manage inventory in down times. The orthopedic supply chain should brace itself for a sharp drop in orders over several months. OEMs specializing in “quality of life” areas of medicine including aesthetic surgery and ophthalmology will also experience a decline in orders.

    Mid-Term Impacts: Financial
    As demand shocks make their way to OEMs and through the supply chain, financial strains will emerge. Over the next 12 months, deferred and diminished orders will show up as cash flow issues, particularly at smaller suppliers and heavily leveraged companies. Bankruptcies are unlikely but constrained cash will limit the operational freedom many OEMs and supply chain companies have enjoyed in recent years. Some companies will slow down hiring and/or defer capital projects.

    Specific financial impacts will vary by area of medicine and by company. As with orthopedics, inventory management will become an increasingly important area of focus to manage cash and resources. Firms with exceptional debt loads may find themselves in discussions with their lenders regarding challenges in meeting bank covenants. Still, the cash flow effects brought on by the epidemic are likely to be limited to three to nine months as companies make difficult cuts to ensure profitable operation.

    Long-Term Impacts: Strategic
    The 2020 coronavirus pandemic will cause OEMs to reevaluate their supplier lists. The most well-known afflictions of the latter 20th century—polio, HIV, malaria, Ebola—were either limited to specific areas or concentrated in populations that device companies rarely served. Not surprisingly, the criterion “supplier is able to provide product reliably despite irregular orders and local sick outs” has not been on the checklist for selecting preferred vendors. In the coming years, OEM procurement teams will consider which suppliers are best suited to survive and supply products in the face of global health issues. Other reactions to the pandemic experience will include an increase in dual sourcing of key components and a preference for larger, more financially stable suppliers with multiple manufacturing sites. These biases will present new challenges for smaller and more leveraged companies, regardless of their expertise. Which firms will be affected? Assume supply chain managers at OEMs will draw their lessons from the worst cases of disruption or perceived instability.

    The Best Approach: Demonstrate Stability in Unstable Times
    As the device industry navigates unchartered and choppy waters, supply chain managers might want to consider how best to present their firms to customers. Suppliers should recognize that OEMs may be dealing with market disruptions. They may not be able to provide accurate information or lead the relationship in the ways they have in more stable times. Rather than ignore or complain about uncertainty, suppliers will be well-served if they can demonstrate plans that show customers they can reliably manufacture regardless of societal disruptions. One action should include calls with customers on how the supplier intends to operate over the next several months. Will production be handled in the traditional way? Will it be shifted to other facilities if needed? Are additional quality steps being considered? Will the supplier’s workforce be screened and offered care if required? Will hours change to accommodate closed schools and daycare? It is essential to show a plan, not “We are trying our best.”

    Suppliers should manage the perception of their readiness to adapt to changing situations. Those that demonstrate competence will be rewarded as their customers look back in the coming years. 


    Tony Freeman is the president of the A.S. Freeman Advisors LLC in New York City. He advises on mergers and acquisition in the specialty materials and precision manufacturing industries. A.S. Freeman Advisors provides a corporate strategy, market planning, and valuation improvement consulting services. Freeman can be contacted at tfreeman@asfreeman.com
    Related Searches
    • medical device
    • diagnostics
    • supplier
    • surgery

    Related Columns

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20


    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20

    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20


    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20

    • COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      Having been a part of the medtech supply chain for 40 years, I can say there has never been a more difficult time for supply chain professionals.
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Next Life Medical; CEO, Emergent Respiratory 11.04.20

    • Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle.
      Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 11.04.20


    • 3D/Additive Manufacturing
      Additive Manufacturing: Debinding Fluids Must-Haves

      Additive Manufacturing: Debinding Fluids Must-Haves

      As the pressure to produce more complex biomedical parts increases, medical device manufacturing using 3D printing is gaining widespread acceptance.
      Venesia Hurtubise, Technical Chemist, MicroCare Medical 11.04.20

    • Diagnostics
       How COVID-19 is Reshaping the Diagnostics Testing Sector

      How COVID-19 is Reshaping the Diagnostics Testing Sector

      The short-term impact on the diagnostics sector is readily apparent as the pandemic has fueled overwhelming demand for effective SARS-CoV-2 testing solutions.
      Eric Williams, Managing Director, Capstone Headwaters 11.04.20

    • Will Industry’s COVID-19 Recovery End Prematurely?

      Will Industry’s COVID-19 Recovery End Prematurely?

      Finally, a light at the end of the tunnel, but will it remain lit?
      Michael Barbella, Managing Editor 10.01.20


    • Surgical
      Hype or Hope? The Future of Surgical Robotics

      Hype or Hope? The Future of Surgical Robotics

      Recent publications suggest the U.S. performs more robotic surgery than every other country in the world.
      Maria Shepherd, President and Founder, Medi-Vantage 10.01.20

    • COVID Community: How the Pandemic Is Bringing Out the Best in Us

      COVID Community: How the Pandemic Is Bringing Out the Best in Us

      Given the brain power and generosity of our industry, I knew I could follow the wisdom of Fred Rogers’ mother and “look for the helpers.”
      Dawn A. Lissy, Founder & President, Empirical 10.01.20

    • Electronics
      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      When looking to outsource the manufacture of electronic medical devices, cleanliness standards and processes should be a top consideration.
      Jay Tourigny, Senior Vice President, MicroCare Medical 10.01.20


    Trending
    • STERIS To Buy Cantel Medical For $4.6B
    • Meeting Critical Ventilator Product Requirements Amid Pandemic
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Abbott To Supply Additional 30M COVID-19 Tests To U.S. Gov't
    Breaking News
    • Optimize EP Launches CaRM Cardiac Device Data Management Platform
    • U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    • FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    • Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    • Moon Surgical Expands Leadership Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NSF Begins New Certification Program
    Eriocitrin Shown to Have Metabolic Benefits in Recent Study
    EverGrain Introduces Sustainable Barley Ingredients
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login